Glenmark Pharma net up 2.08 times in Mar`08 qtr

[B. KARTHICK]

Glenmark Pharmaceutical announced a phenomenal rise in standalone net
profit for the quarter ended March 2008. During the quarter, the
profit of the company rose 2.08 times to Rs 1,301.41 million from Rs
625.63 million in the same quarter previous year. The company posted
earnings of Rs 5.24 a share during the quarter, registering 0.38%
growth over previous year period.

Net sales for the quarter jumped 44.44% to Rs 3,968.98 million, while
total income for the quarter jumped 48.69% to Rs 4,119.06 million,
when compared with the prior year period.


Quarterly Results - standalone (Rs in mn)
As at Mar - 08 Mar - 07 %Change
Net Sales 3968.98 2747.93 44.44
Net Profit 1301.41 625.63 108.02
Basic EPS 5.24 5.22 0.38


During the quarter the company announced a fall in operating margin by
393.20 basis points to 29.09% on higher production cost. On the other
hand, there has been increase of 35.09% in interest charge to Rs 91.44
million and rise of 37.96% in depreciation charge to Rs 81.70 million
over previous year period